Activity of dasatinib (BMS-354826), a dual SRC/ABL kinase inhibitor, and IPI-504, a heat shock protein 90 inhibitor, against thet imatinib-resistant PDGFRαD842V catalytic domain mutation in gastrointestinal stromal tumors

Dewaele, Barbara

Cools, Jan ; Sciot, Raphael ; Wozniak, Agnieszka ; Prenen, Hans ; Vandenberghe, Peter ; Schöffski, Patrick ; Marynen, Peter ; Debiec-Rychter, Maria